|
|
||||||||
The Journal of Immunology, Vol 156, Issue 1 153-159, Copyright © 1996 by American Association of Immunologists
ARTICLES |
NS Williams and VH Engelhard
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Although cytotoxic activity has generally been shown to reside in the CD8+ population of T lymphocytes, there are numerous examples of cytotoxic CD4+ T cells. In the present study, we found that after depletion of CD8+ T cells, CD4+ T cells cultured in short-term in vitro mixed lymphocyte cultures developed strong Ag-specific cytotoxic activity. Such CD4+ CTL lysed both Fas+ and Fas- target cells and developed in Fas ligand-deficient gld mice. Thus, in contrast to several recent reports involving long-term T cell clones or short-term mitogen-activated splenocytes, the cytotoxic activity of these CD4+ CTL is not dependent on Fas-Fas ligand interactions. However, CD4+ cells derived in a similar manner from perforin knockout mice showed greatly decreased target cell lysis, indicating that their cytotoxic activity is primarily dependent on a perforin-based mechanism. The Fas-Fas ligand pathway has been shown to be important in the maintenance of peripheral tolerance, but to have a minimal role in protection against viral and bacterial pathogens. Thus, the existence of a population of CD4+ CTL that utilizes perforin re-emphasizes the likely importance of these cells in a classical defensive role against foreign pathogens, in addition to their already implied role as modulators of the immune response.
This article has been cited by other articles:
![]() |
S. Mostbock, M. Catalfamo, Y. Tagaya, J. Schlom, and H. Sabzevari Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis Blood, March 15, 2007; 109(6): 2488 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Zheng, L. L. Ma, G. J. Jones, M. J. Gill, A. M. Krensky, P. Kubes, and C. H. Mody Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients Blood, March 1, 2007; 109(5): 2049 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Charalambous, M. Oks, G. Nchinda, S. Yamazaki, and R. M. Steinman Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin J. Immunol., December 15, 2006; 177(12): 8410 - 8421. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Shen, J. S. Y. Ma, J. Mather, S. Vukmanovic, and S. Radoja Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells J. Leukoc. Biol., October 1, 2006; 80(4): 827 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Brown, A. M. Dilzer, D. L. Meents, and S. L. Swain CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol., September 1, 2006; 177(5): 2888 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lambe, J. C. H. Leung, T. Bouriez-Jones, K. Silver, K. Makinen, T. L. Crockford, H. Ferry, J. V. Forrester, and R. J. Cornall CD4 T Cell-Dependent Autoimmunity against a Melanocyte Neoantigen Induces Spontaneous Vitiligo and Depends upon Fas-Fas Ligand Interactions. J. Immunol., September 1, 2006; 177(5): 3055 - 3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Cohen, Z. Zheng, R. Bray, Y. Zhao, L. A. Sherman, S. A. Rosenberg, and R. A. Morgan Recognition of Fresh Human Tumor by Human Peripheral Blood Lymphocytes Transduced with a Bicistronic Retroviral Vector Encoding a Murine Anti-p53 TCR J. Immunol., November 1, 2005; 175(9): 5799 - 5808. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Jellison, S.-K. Kim, and R. M. Welsh Cutting Edge: MHC Class II-Restricted Killing In Vivo during Viral Infection J. Immunol., January 15, 2005; 174(2): 614 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Schultz, B. Schuler-Thurner, V. Stroobant, L. Jenne, T. G. Berger, K. Thielemanns, P. van der Bruggen, and G. Schuler Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy J. Immunol., January 15, 2004; 172(2): 1304 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Moore, C. C. Brown, and K. R. Spindler T Cells Cause Acute Immunopathology and Are Required for Long-Term Survival in Mouse Adenovirus Type 1-Induced Encephalomyelitis J. Virol., September 15, 2003; 77(18): 10060 - 10070. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Staska, T. C. McGuire, C. J. Davies, H. A. Lewin, and T. V. Baszler Neospora caninum-Infected Cattle Develop Parasite-Specific CD4+ Cytotoxic T Lymphocytes Infect. Immun., June 1, 2003; 71(6): 3272 - 3279. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Omiya, C. Buteau, H. Kobayashi, C. V. Paya, and E. Celis Inhibition of EBV-Induced Lymphoproliferation by CD4+ T Cells Specific for an MHC Class II Promiscuous Epitope J. Immunol., August 15, 2002; 169(4): 2172 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. VanLith, K. G. Kohlgraf, C. L. Sivinski, R. M. Tempero, and M. A. Hollingsworth MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses Int. Immunol., August 1, 2002; 14(8): 873 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Appay, J. J. Zaunders, L. Papagno, J. Sutton, A. Jaramillo, A. Waters, P. Easterbrook, P. Grey, D. Smith, A. J. McMichael, et al. Characterization of CD4+ CTLs Ex Vivo J. Immunol., June 1, 2002; 168(11): 5954 - 5958. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Topham, R. C. Cardin, J. P. Christensen, J. W. Brooks, G. T. Belz, and P. C. Doherty Perforin and Fas in murine gammaherpesvirus-specific CD8+ T cell control and morbidity J. Gen. Virol., August 1, 2001; 82(8): 1971 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dobbs and K. Haskins Comparison of a T Cell Clone and of T Cells from a TCR Transgenic Mouse: TCR Transgenic T Cells Specific for Self-Antigen Are Atypical J. Immunol., February 15, 2001; 166(4): 2495 - 2504. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Chang, L. Galle, D. Maggs, D. M. Estes, and W. J. Mitchell Pathogenesis of Herpes Simplex Virus Type 1-Induced Corneal Inflammation in Perforin-Deficient Mice J. Virol., December 15, 2000; 74(24): 11832 - 11840. [Abstract] [Full Text] |
||||
![]() |
S. Hegde and J. Y. Niederkorn The Role of Cytotoxic T Lymphocytes in Corneal Allograft Rejection Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3341 - 3347. [Abstract] [Full Text] |
||||
![]() |
C. Traidl, S. Sebastiani, C. Albanesi, H. F. Merk, P. Puddu, G. Girolomoni, and A. Cavani Disparate Cytotoxic Activity of Nickel-Specific CD8+ and CD4+ T Cell Subsets Against Keratinocytes J. Immunol., September 15, 2000; 165(6): 3058 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Hsieh and R. Korngold Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses Blood, August 1, 2000; 96(3): 1047 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saijo, X. Hong, M. Tanaka, R. Tazawa, S. Q. Liu, K. Saijo, T. Ohno, K. Koike, K. Ohkuda, K. Satoh, et al. Autologous High-Killing Cytotoxic T Lymphocytes against Human Lung Cancer Are Induced Using Interleukin (IL)-1{beta}, IL-2, IL-4, and IL-6: Possible Involvement of Dendritic Cells Clin. Cancer Res., May 1, 1999; 5(5): 1203 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohminami, M. Yasukawa, S. Kaneko, Y. Yakushijin, Y. Abe, Y. Kasahara, Y. Ishida, and S. Fujita Fas-Independent and Nonapoptotic Cytotoxicity Mediated by a Human CD4+ T-Cell Clone Directed Against an Acute Myelogenous Leukemia-Associated DEK-CAN Fusion Peptide Blood, February 1, 1999; 93(3): 925 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Stohl, D. H. Lynch, G. C. Starling, and P. A. Kiener Superantigen-Driven, CD8+ T Cell-Mediated Down-Regulation: CD95 (Fas)-Dependent Down-Regulation of Human Ig Responses Despite CD95-Independent Killing of Activated B Cells J. Immunol., October 1, 1998; 161(7): 3292 - 3298. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang and G. A. Splitter CD4+ Cytotoxic T-Lymphocyte Activity against Macrophages Pulsed with Bovine Herpesvirus 1 Polypeptides J. Virol., September 1, 1998; 72(9): 7040 - 7047. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rivoltini, M. Radrizzani, P. Accornero, P. Squarcina, C. Chiodoni, A. Mazzocchi, C. Castelli, P. Tarsini, V. Viggiano, F. Belli, et al. Human Melanoma-Reactive CD4+ and CD8+ CTL Clones Resist Fas Ligand-Induced Apoptosis and Use Fas/Fas Ligand-Independent Mechanisms for Tumor Killing J. Immunol., August 1, 1998; 161(3): 1220 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Spaner, K. Raju, L. Radvanyi, Y. Lin, and R. G. Miller A Role for Perforin in Activation-Induced Cell Death J. Immunol., March 15, 1998; 160(6): 2655 - 2664. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. McCarthy, M. S. Mainwaring, D. S. Dougall, and E. S. Lamouse-Smith Activation Requirements, Lytic Mechanism, and Development of a Novel Anti-CD8-Resistant CTL Population J. Immunol., March 15, 1998; 160(6): 2715 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lewinsohn, T. T. Bement, J. Xu, D. H. Lynch, K. H. Grabstein, S. G. Reed, and M. R. Alderson Human Purified Protein Derivative-Specific CD4+ T Cells Use Both CD95-Dependent and CD95-Independent Cytolytic Mechanisms J. Immunol., March 1, 1998; 160(5): 2374 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Antel, E. McCrea, U. Ladiwala, Y.-f. Qin, and B. Becher Non-MHC-Restricted Cell-Mediated Lysis of Human Oligodendrocytes In Vitro: Relation with CD56 Expression J. Immunol., February 15, 1998; 160(4): 1606 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zajac, D. G. Quinn, P. L. Cohen, and J. A. Frelinger Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection PNAS, December 10, 1996; 93(25): 14730 - 14735. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |